FORA
Forian Inc.NASDAQHealthcareAs of 2026-04-07
Valuation
View DetailsP/E (TTM)
—
PEG
—
P/B
2.25
P/S
2.21
EV/EBITDA
-24.09
DCF Value
$-11.90
FCF Yield
4.3%
Div Yield
0.0%
Margins & Returns
Gross Margin
52.5%
Operating Margin
-8.2%
Net Margin
-9.5%
ROE
-9.4%
ROA
-6.5%
ROIC
-8.3%
Financials
View All| Period | Revenue | Net Income | EPS |
|---|---|---|---|
| Q4 2025 | $8.0M | $-1.8M | $-0.06 |
| FY 2025 | $30.3M | $-2.9M | $-0.09 |
| Q3 2025 | $7.8M | $-151.2K | $-0.00 |
| Q2 2025 | $7.5M | $224.8K | $0.01 |
Analyst Ratings
View AllConsensus
Hold
Target (Consensus)
$4.50
Target (Median)
$4.50
Target Range
$4.50 - $4.50
Trading Activity
Insider Trades
View AllCompany Info
Sector
Healthcare
Industry
—
Country
US
Exchange
NASDAQ
Beta
0.99
Forian Inc. provides software solutions, proprietary data driven insights, and predictive analytics to optimize the operational, clinical, and financial performance of its healthcare, cannabis, and government customers. It operates through three segments: Information & Software, Services, and Other. The company's products include BioTrack, a vertically integrated point of sale, manufacturing, delivery, and cultivator software solution for dispensaries, cultivators, manufacturers, and distributors; and Cannalytics, a Software as a Service based analytics solution that provides clients with a presentation of business performance. Its products also comprise BioTrack seed-to-sale compliance traceability platform, which is used to manage the tracking and tracing of various cannabis products from cultivation to sale; BioTrack State Traceability & Enforcement Monitoring System to ensure transparency and accountability throughout cannabis supply chain; and STEMS, a seed-to-sale tracking module, to provide cannabis program management solution to cannabis regulatory agencies. In addition, the company offers security monitoring and web marketing services. The company is headquartered in Newtown, Pennsylvania.